AIVI0.250%
as of Jul 17
FRE
GrowthFRESENIUS SE & CO KGAA /EUR/
Close · 3M
-1.46%
Held by 2 AI ETFs
PQNT0.050%
as of Jul 21
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals2
Win rate0% (0/1)
Avg buy return-2.59%
AIVI · Weight decrease · 2d
FRESENIUS SE & CO KGAA (FRE), a Health Care sector company, initially received a 0.2596% allocation in AIVI on July 6, 2026, following zero weight, before its portfolio weight consistently decreased over subsequent days, settling at 0.2454% by July 14. This sustained, gradual reduction in exposure suggests an AI-driven recalibration by WisdomTree's AIVI. Operating within a developed-international value-factor pool, the AI selection mechanism likely registered subtle, evolving changes in FRE's perceived value characteristics relative to other ~100 international value stocks in the portfolio. Such a measured adjustment indicates the AI's periodic rebalance is systematically de-emphasizing FRE, aligning with an international value strategy that continuously seeks optimal allocation in this comparatively underserved market corner.
weight 0.256% → 0.245% (-0.010 pp)
Jul 14·now $46.98
price n/a
price n/a
PQNT · Weight increase · 2d
The AI ETF likely identified a positive catalyst or improving sentiment for Fresenius (FRE) within the Health Care sector, potentially driven by fundamental data, technical indicators, or a perceived buying opportunity after a slight dip. Retail investors can view such consecutive increases as a potential signal for further research, but must conduct their own due diligence and consider their risk tolerance, as AI decisions are algorithm-driven and not infallible.
weight 0.100% → 0.150% (+0.050 pp)
May 10·entry $48.23·now $46.98Fresh
-2.59%
since May 10
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.